0 NASDAQ Companies - September 23, 2019BioCryst Appoints Helen Thackray, M.D., to Board of DirectorsRead More
0 NASDAQ Companies - September 23, 2019Athenex Completes Construction of New API Facility in ChongqingRead More
0 NASDAQ Companies - September 23, 2019Athenex to Present at the 2019 San Antonio Breast Cancer SymposiumRead More
0 NASDAQ Companies - September 23, 2019Ovid Therapeutics Announces Positive Initial Data from Ongoing ENDYMION Open-Label Extension Trial of Soticlestat in People with Rare EpilepsiesRead More
0 NASDAQ Companies - September 23, 2019Scilex Holding Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public OfferingRead More
0 NASDAQ Companies - September 23, 2019Athenex to Highlight Oral Paclitaxel Clinical Programs Targeting Various Solid Tumors at the ESMO Congress 2019Read More
0 NASDAQ Companies - September 23, 2019ReWalk Robotics to Present at the Sidoti & Company Conference on September 25thRead More
0 NASDAQ Companies - September 23, 2019Akcea Announces CEO Transition and Elects Two New Board MembersRead More
0 NASDAQ Companies - September 23, 2019Cyclacel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare ConferenceRead More
0 NASDAQ Companies - September 23, 2019GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsyRead More
